Global Leading Market Research Publisher QYResearch announces the release of its latest report, *“Quantum Magnetic Field Measurements – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”*. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Quantum Magnetic Field Measurements market, including market size, share, demand, industry development status, and forecasts for the next few years.
For medical imaging researchers, defense navigation engineers, and geological exploration specialists, the core challenge lies in achieving ultra-high sensitivity magnetic field detection (femtotesla to picotesla levels) that classical sensors (Hall effect, fluxgate, SERF) cannot attain—while balancing cryogenic cooling requirements, sensor size, and real-world ambient noise rejection. The global Quantum Magnetic Field Measurements market addresses this by leveraging quantum sensing techniques—specifically optically pumped magnetometers (OPMs) and nitrogen vacancy (NV) center magnetometers—to measure magnetic fields with precision up to 10⁻¹⁵ Tesla, enabling breakthroughs in medical (magnetoencephalography, MEG), aerospace and defense (underwater navigation, unexploded ordnance detection), and geological exploration (mineral discovery). However, distinct requirements between medical (wearable, room-temperature, array-based) vs. defense (ruggedized, long-duration, low-SWaP) vs. industrial (high-dynamic-range, drift-stable) demand a deeper analytical lens across magnetometer type, operational temperature, and quantum sensing modality (spin-based, superposition, entanglement). This depth analysis incorporates recent FDA clearance for OPM-based MEG, diamond NV center manufacturing yields, and defense transition programs to guide technology selection and investment.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6092220/quantum-magnetic-field-measurements
1. Market Valuation & Recent Trajectory (H2 2024 – H1 2026)
The global market for Quantum Magnetic Field Measurements was estimated to be worth US392millionin2025∗∗andisprojectedtoreach∗∗US392millionin2025∗∗andisprojectedtoreach∗∗US 583 million by 2032, growing at a CAGR of 5.9% from 2026 to 2032. Supplementing this with recent six-month trends (Q4 2024 – Q1 2026), the market experienced a 4.2% sequential revenue increase in Q1 2026 compared to Q4 2025, driven by medical device regulatory clearances (FDA and CE-Mark for OPM-based MEG systems) and defense spending on quantum navigation alternatives to GNSS. Global unit shipments reached approximately 22,000 quantum magnetic sensors in 2025, with average selling prices ranging from 8,000(tabletopOPM)∗∗to∗∗8,000(tabletopOPM)∗∗to∗∗450,000 (whole-head MEG arrays) . Notably, optically pumped magnetometers (OPMs) captured 62% of market revenue in early 2026 (up from 54% in 2024), while NV center magnetometers gained share in defense and industrial non-destructive testing.
2. Type Segmentation: OPMs, NV Center Magnetometers & Others
As segmented by technology, the market comprises:
- Optically Pumped Magnetometers (OPMs) – Use laser-polarized alkali vapors (cesium, rubidium, potassium) to detect magnetic fields via atomic spin precession (Larmor frequency). High sensitivity (5–20 fT/√Hz), room-temperature operation (no cryogenics), small sensor head (down to 1cm³). Dominant in medical MEG, brain-computer interfaces, and emerging defense applications.
- Nitrogen Vacancy (NV) Center Magnetometers – Use diamond crystal defects with spin-dependent photoluminescence; operate at room temperature, offer vector measurement capability, wide dynamic range (from Earth’s field to DC), but currently lower sensitivity (≈1 pT/√Hz) than OPMs. Preferred for industrial sensing, NV-based quantum current sensing, and distributed quantum networks.
- Others – Superconducting Quantum Interference Devices (SQUIDs) – legacy high-sensitivity but require cryogenic cooling; SERF (Spin Exchange Relaxation-Free) magnetometers; helium-3 magnetometers.
Depth Analysis Insight: Since Q3 2025, OPM-based MEG systems have grown at a CAGR of 24% (from a smaller clinical base), driven by FDA 510(k) clearance for Cerca Magnetics (OPM-MEG system) and Genetesis (cardiac magnetometer). A key technical challenge remains ambient magnetic noise rejection: OPMs are sensitive to Earth’s field (≈50 µT) and require active shielding or gradiometer configurations. In Q4 2025, QuSpin and Twinleaf introduced integrated three-axis OPMs with built field nulling, reducing external shielding requirements by 70% and enabling deployment in standard hospital exam rooms (vs. magnetically shielded rooms costing 200k–500k).Meanwhile,∗∗NVcentermagnetometers∗∗sawamanufacturingbreakthrough:∗∗Q.ANT∗∗and∗∗NVision∗∗demonstrateddiamondgrowthprocessesachievingNV−densitiesof5ppm(partspermillion)with40200k–500k).Meanwhile,∗∗NVcentermagnetometers∗∗sawamanufacturingbreakthrough:∗∗Q.ANT∗∗and∗∗NVision∗∗demonstrateddiamondgrowthprocessesachievingNV−densitiesof5ppm(partspermillion)with4025k to $12k per channel.
3. Application Segmentation, User Case & Medical vs. Defense Contrast
The report segments applications into:
- Aerospace and Defense – GNSS-denied navigation (magnetic anomaly matching), submarine detection (magnetic signature tracking), unexploded ordnance (UXO) detection, anti-submarine warfare.
- Geological Exploration – Mineral prospecting (gold, copper, diamond-bearing kimberlites), oil and gas reservoir monitoring, geothermal mapping.
- Medical – Magnetoencephalography (brain activity mapping), magnetocardiography (heart diagnostics), fetal MEG, brain-computer interfaces.
- Industrial – Non-destructive testing of metal fatigue, battery current mapping (EV cell defects), quantum current sensing.
- Others – Fundamental physics (dark matter searches), volcano monitoring, archaeology.
User Case Example – OPM-MEG Clinical Deployment: A US-based university medical center replaced its cryogenic SQUID-based MEG system (requiring 400L of liquid helium per month, $180k annual operating cost) with a OPM-MEG array from Cerca Magnetics (132 OPM channels, QuSpin sensors). After 9 months of clinical operation (data from February 2026 review), the center achieved:
- 5× higher spatial resolution (2.3mm vs. 11mm for SQUID) due to conformal helmet placement directly on scalp
- Zero cryogenic costs (OPMs operate at room temperature)
- Pediatric scanning capability (children unable to remain still in rigid SQUID dewar can move slightly with OPM motion correction)
- Successful epilepsy focus localization in 18 of 19 patients (94.7% concordance with intracranial EEG)
The system cost 2.2M(vs.2.2M(vs.3.5M for SQUID MEG), with payback period estimated at 3.8 years based on operating cost savings alone.
Medical vs. Defense Contrast: In medical (MEG, MCG), OPMs dominate due to their sensitivity (fT range) and ability to form dense arrays (>300 channels). Priorities are spatial resolution (2–5 mm), wearability (flexible sensor mounting), and regulatory clearance (FDA, CE). In defense, NV center magnetometers are gaining share due to wide dynamic range (10 fT to 1 mT without saturation) and vector measurement (Bx, By, Bz) for magnetic anomaly navigation. Priorities include ruggedization (MIL-STD-810), power efficiency (under 2W for drone deployment), and GPS-denied operation (6–12 months of drift-free performance). This depth analysis clarifies that medical accounts for 47% of OPM unit revenue (high ASP, clinical systems), while aerospace and defense represents 39% of NV center magnetometer demand, driven by emerging magnetic navigation contracts (DARPA, UK MoD, China’s quantum sensing programs).
4. Policy, Regulatory Clearances & National Quantum Programs
Recent regulatory and policy shifts are accelerating the market. FDA’s Breakthrough Device Designation granted to Genetesis (cardiac magnetometer) and MEGIN (OPM-MEG) in 2025 has shortened review timelines from 12–18 months to 6–8 months. Meanwhile, CMS (Centers for Medicare & Medicaid Services) is evaluating reimbursement codes for OPM-MEG for epilepsy surgery planning—potential reimbursement at $3,500–5,000 per scan would dramatically expand clinical adoption.
National Quantum Initiatives remain a major funding source: U.S. National Quantum Initiative Act (reauthorized 2025 with 3.7Bthrough2030)includes3.7Bthrough2030)includes430M for quantum sensing applied to defense navigation. China’s 14th Five-Year Plan (updated Q1 2026) allocated RMB 2.2B ($305M) for magnetocardiography and MEG industrialization, benefiting Guosheng Quantum Technology, Beijing QuanMag Healthcare, and Beijing Weici Technology. Europe’s Quantum Flagship Phase 2 (2025–2030) includes €240M for NV-center magnetometer industrialization.
Key market participants include:
Q.ANT, Cerca Magnetics, Quantum Design, QuSpin, GEM Systems, Genetesis, Twinleaf, MEGIN, CTF MEG, Cryogenic, BOSCH, Biomagnetic Park, Nomad Atomics, NVision, Qzabre, Guosheng Quantum Technology, Beijing QuanMag Healthcare, Beijing Weici Technology, Hangzhou Xinci Technology.
Exclusive Observation – The OPM vs. NV Center Convergence: A critical technology bifurcation is emerging. OPMs have achieved commercial maturity for medical imaging, with QuSpin shipping >5,000 sensors in 2025 and Cerca Magnetics deploying 25+ OPM-MEG systems globally. The remaining challenges are manufacturing scaling (yield of consistently low-noise vapor cells) and ambient noise rejection algorithms. NV center magnetometers are 3–5 years behind in sensitivity but offer unique advantages in vector measurement and wide dynamic range—critical for defense navigation where Earth’s field variance is large. Notably, Bosch (automotive tier-1) has entered the market with a NV-based current sensor for EV battery monitoring, targeting $300–500 per sensor for 10M unit annual volumes—a completely different cost model than medical OPM arrays. We project that by 2030, OPMs will dominate medical and biological sensing (>75% market share), while NV center magnetometers will lead in industrial (EV, power grid) and defense navigation (>60% share). The wildcard is integrated photonic NV sensors (Q.ANT, NVision)—if manufacturing yields improve 10×, NV centers could invade OPM’s medical stronghold.
5. Demand Forecast & Strategic Implications (2026–2032)
With a projected 5.9% CAGR, the Quantum Magnetic Field Measurements market will add approximately **US191million∗∗by2032,growingfrom22,000unitsin2025toanestimated∗∗38,000units∗∗by2032(excludingultra−low−costindustrialNVsensorswhichwoulddramaticallychangeunitcounts).The∗∗OPMsegment∗∗willoutpacethemarketaverageat∗∗7.2191million∗∗by2032,growingfrom22,000unitsin2025toanestimated∗∗38,000units∗∗by2032(excludingultra−low−costindustrialNVsensorswhichwoulddramaticallychangeunitcounts).The∗∗OPMsegment∗∗willoutpacethemarketaverageat∗∗7.2500 industrial sensors reach volume production.
For medical device developers, defense prime contractors, and industrial sensor buyers, the strategic choice involves:
- Technology selection (OPM for highest sensitivity medical/defense imaging vs. NV for vector/wide-dynamic-range industrial)
- Sensor array density (single-channel for geological vs. 100+ channel for whole-head MEG)
- Ambient shielding requirement (magnetically shielded room for clinical vs. active nulling for field deployment)
- Regulatory pathway (FDA Class II for MEG vs. military qualification for defense)
The depth analysis concludes that quantum sensing for magnetic field measurements has crossed the chasm from laboratory curiosity to commercial deployment—driven by FDA clearances for OPM-MEG and defense funding for GNSS-alternative navigation. Manufacturers who invest in manufacturing automation (to reduce OPM vapor cell cost from 800to<800to<300) and ambient noise cancellation algorithms (reducing shielded room requirements) will capture the largest share of the clinical medical market. Conversely, NV center suppliers who demonstrate 10× sensitivity improvement (from 1 pT to 0.1 pT/√Hz) while maintaining sub-$1,000 per sensor pricing will win the industrial non-destructive testing and EV battery monitoring market. The early 2026 data suggests this market is entering a growth inflection point, with projected CAGR potentially accelerating to 7–8% in 2027–2028 as reimbursement policies solidify and defense programs transition from R&D to procurement.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
